{"name":"AMAG Pharmaceuticals, Inc.","slug":"amag-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":327751000,"revenueGrowth":265.4,"grossMargin":0,"rdSpend":0,"netIncome":-466456000,"cash":791227000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2019"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"FCM","genericName":"FCM","slug":"fcm","indication":"Iron deficiency anemia in patients with chronic kidney disease","status":"phase_3"},{"name":"ferumoxytol or oral iron","genericName":"ferumoxytol or oral iron","slug":"ferumoxytol-or-oral-iron","indication":"Treatment of iron deficiency anemia in adult patients with chronic kidney disease","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ASQ-3, Bayley III, Neurologic exam","genericName":"ASQ-3, Bayley III, Neurologic exam","slug":"asq-3-bayley-iii-neurologic-exam","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"FCM","genericName":"FCM","slug":"fcm","phase":"phase_3","mechanism":"FCM (ferric carboxymaltose) delivers iron directly into the bloodstream to replenish iron stores and treat iron deficiency anemia.","indications":["Iron deficiency anemia in patients with chronic kidney disease","Iron deficiency anemia in patients intolerant to or with inadequate response to oral iron","Postpartum iron deficiency anemia"],"catalyst":""},{"name":"ASQ-3, Bayley III, Neurologic exam","genericName":"ASQ-3, Bayley III, Neurologic exam","slug":"asq-3-bayley-iii-neurologic-exam","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ferumoxytol or oral iron","genericName":"ferumoxytol or oral iron","slug":"ferumoxytol-or-oral-iron","phase":"phase_3","mechanism":"Ferumoxytol is an intravenous iron replacement therapy that works by replenishing iron stores in the body.","indications":["Treatment of iron deficiency anemia in adult patients with chronic kidney disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxQMWE1d0ZBY1AzTW9DdVF0YjE5OGl4Q2Zfd0lDY0dHTGdaRjk3X0tCZzBtSGV1NXpHNkRFcER6dnBDZWpuenNzS1VXc2JhTmZDWW9WaVFZNmJ6eVBoN2dpVFFTZFhtdXFHLTllUlRHdUxYNGxreUpLN2s3Z1ljUTBWZVpOVTEwRVBWRXctNUN4a2l6SmNFME5EUnZSRnFjMjRjNlpZMHBTVjhEY3hPNzJPNjFWMDlTTzV4LXh4VlJ6aFlHNElXcXlYcElVQ0U0dEc3VG83UzFpRmtSWk5BZEJKa0NaU1RrczV1NF9LS2c2RnpQSmo0cVRIeUdLS1ZwSTNldU8tYWVneWpFM1hITUdCNkFPR0ZrVXE0SXVfOWdwLWhxb1A2dGNEa2FSXzFPMHU1WUs5TA?oc=5","date":"2026-03-04","type":"pipeline","source":"PR Newswire","summary":"Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight - PR Newswire","headline":"Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE03UHZ0T1Z5eEJyWnVzbzlxYnB6UF9BdVFDWk1NMzkzRU9UcVd0NXFuOFg1REVXdXpPVl9zRkRjaXI4T3hSenlqTkRCejdwR2d3TER5UGI5bkZuNjRsUlQzX3JoMnJtdUhXaHBB?oc=5","date":"2025-11-27","type":"pipeline","source":"Fact.MR","summary":"Intravenous Iron Drugs Market | Global Market Analysis Report - 2035 - Fact.MR","headline":"Intravenous Iron Drugs Market | Global Market Analysis Report - 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNN1NHNFU4anlkaEk3YmFYUW1HeUZZRFBFSUhHU3ItUEEtc0dsZnNadlVJb2tMMmJHZzU3SFk4YlZESTQxV1VSVzhSZk93RVZMTjhXNnYzbzRxMF8yeUtJZDdtM2p2bl81SFdrclA4bGdMNDRlUnVlVmhxWVhlT2NqcElENWVBS0E?oc=5","date":"2023-10-26","type":"pipeline","source":"Yahoo Finance","summary":"Iron Deficiency Anemia Market Size and Share to Grow by 2032, Predicts DelveInsight | Leading Companies Developing Therapies - Pharmacosmos, AMAG, Shield, Akebia, Keros, Keryx Biopharmaceuticals, Sier","headline":"Iron Deficiency Anemia Market Size and Share to Grow by 2032, Predicts DelveInsight | Leading Companies Developing Thera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOE9FRTVpMjVOYmJlUDdaLVBveEdWVC00LXpCOVRXamRRVW9Udm82bGN2WHl1ZTRTNHFlME9BQ1dqbjFLOXE2RmN6YkdFc2tHa0pOcW9CUWJVMXB2Y3JyX1hGTnRyRGEwTmtVbWhaMGJMR2JvM2h6d2hBb0JRTnNYdUt2UzdDMnlSUjlvRktEc3FwaFE?oc=5","date":"2021-03-29","type":"pipeline","source":"Amylyx","summary":"Paul Fonteyne Joins Amylyx Pharmaceuticals Board of Directors - Amylyx","headline":"Paul Fonteyne Joins Amylyx Pharmaceuticals Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE03YWpoNG5VVEJnenFuTEp6eEhrRUl1ZEJtSFpjQklEMGtndG5xdExraDBBQUlIaDNQSGoxZ0llVlZ5XzZsZDRvLUd3Z2ZyM1A5QlR5WVdUemhNVEJnRGphZTk4MFRfVjVFNkJUdDdFOWs?oc=5","date":"2020-10-02","type":"deal","source":"BioSpace","summary":"Covis Group to Acquire AMAG Pharmaceuticals in $647 Million Deal - BioSpace","headline":"Covis Group to Acquire AMAG Pharmaceuticals in $647 Million Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNR29JVEFoeGh0dU9KQ2xUNG4tczEwQVlxalhPQ05CekotZy1pM05ja3dUQW40SGlZZmhRTGJMUEhHaldrWGJBMkRmdGxTcFJWemVGNFp4RVBPTEVFSWxnV2tDNTI3NXJlNk9kaDVHREV6T1dMd1Z2WmxiM3B5NkVtWEx2alp0dw?oc=5","date":"2020-10-01","type":"deal","source":"BioPharma Dive","summary":"Private equity-backed Covis to buy AMAG Pharma in $650M deal - BioPharma Dive","headline":"Private equity-backed Covis to buy AMAG Pharma in $650M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQVEZ5Sjc3SGMyY0VOYkZKUEQxTlV1clZPdFRuTm9OUTZTSzBOQ0xhRzZuQkZoTlV0ck1qNk1GVWxtaEFsYUtrSE16UUNFMHpDcTFiRGtOVk0wOEdmY3NOV0ZhcHB5LUNwNFBqWDE2RFNKbnJvS29hQmxBclFjS19hUkxLSm9CZnhUVENIV2c0VnFlS09E?oc=5","date":"2020-10-01","type":"deal","source":"Contract Pharma","summary":"Covis Agrees to Acquire AMAG Pharmaceuticals - Contract Pharma","headline":"Covis Agrees to Acquire AMAG Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNVDFuRHdpU3gzTnVHZEVzcWpTN3ljVkllLVFPeFhUUlNCdlZwWmVObFp6blR4S2czSWVoTWF1a3R0dlNzSHNmUDhQSGRJWGNLNmc0VTBLd2tGLURPbllfbWpJbVotQ1MyQ2YwN0RNRk1rV3pxd1IxRW4zTTB4N25wUW4xQWFYUHpHcG9sNGJLMndYeWFZNlh5MXU3Qm1wY1gyV2ktVkk0Q0taOGdJMDJYQXJpTHNWR3N5bHNyRU9BQjlyN1B2VzlFY3liZVNJTnlGNW1xa2t4YmZSa09MbV9nWFp5d2Z5bVZRRWF3TnRjQVptaHJPOGZwdEktaW5BNlN4aUpJT3JITQ?oc=5","date":"2020-05-21","type":"pipeline","source":"GlobeNewswire","summary":"AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million - GlobeNewswire","headline":"AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNY053bFZjWHdYMllvUWZhTXBfNDVwSzNzMVZ1cFlqc0FfREZ0RXA1cHZMbV84WUVUNmdlU00yYkw5d2dLODlKOTJFa2JUbWo2OWZ3QVdiNjFIdG5UZTlxaEZqc1c4cjhweTVtdzNGMUIydGZfWlNtSlZwai1zUUNyMDdIVWtXamRYSG1fWjkzbU9Tcm9Hb0M1emptc21YSFdCMktHalItY3g0dEdlZ0h3?oc=5","date":"2019-06-21","type":"regulatory","source":"Fierce Pharma","summary":"AMAG wins FDA nod for Vyleesi. Could it be the ‘female Viagra’ that Addyi never was? - Fierce Pharma","headline":"AMAG wins FDA nod for Vyleesi. Could it be the ‘female Viagra’ that Addyi never was?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNNGNZY3BhcUN5X1hBYkNJNDd5ZWhDRXNzcl9FTkVJTW5FcGhsTThIb3N0X1JDVWxjWEJZbjA1d1ZINjJYM2pfUHoySXVRMXdZQTdKblROQ3lpNzFIZ3lwWE9PMFVac1JZdXZ3Q3UtM2pFRm1ZZXZXQmdvN0hsTUxtZjRoUEVscGh3VFR4eFE2LWJLdmJHZEdWS2Z2LS16WDUwLVdOcWZ6dnJ2YTFldUsyNDlYOA?oc=5","date":"2019-06-18","type":"regulatory","source":"Bloomberg.com","summary":"Sex Drug’s FDA Approval Could Spur Turnaround for Amag Pharma Shares - Bloomberg.com","headline":"Sex Drug’s FDA Approval Could Spur Turnaround for Amag Pharma Shares","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQZWVacUQ2S0Fwemt2cFdxeGpHOUhyZW9HV2pNWmNEdHJlSTNCQzk4Unc1dDNwV0otMmhDNTh2RjBIaE1MMlJBUDRkRmlZekpGeHN1X292Qm9YWHF6VVBZNTh3dF94Z2FCVHcwNGxocURxLU9JLTRwVU5JLXJIWnhkVkVIVGxXTE9HeEtnY0x1Q0ItWkd3eU5vdXRSUmZvUQ?oc=5","date":"2018-02-15","type":"pipeline","source":"The Motley Fool","summary":"Why AMAG Pharmaceuticals, Inc. and Antares Pharma, Inc. Are Soaring Today - The Motley Fool","headline":"Why AMAG Pharmaceuticals, Inc. and Antares Pharma, Inc. Are Soaring Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE5qQ2l3aXJpd1lsbktlLWpUeWlseHhrNU51VVZhNmZWYjRUN084TEV1VjZYX2hHVV9oOWR2MlJBR2tZLWt2VHh1MUJrNURFUdIBU0FVX3lxTFBUTjE0WmNkblpBVG0yUlhqSXotb2c2VkZqMU9sS3F3TUVpampFVUhGTktJLTV5bDJiZnJORkp0STREMWJDUnFmNDAzQnBxYzJzX3J3?oc=5","date":"2015-07-09","type":"pipeline","source":"BioInformant","summary":"3 Eerie Similarities between the Acquisition of Cord Blood Registry® (CBR) and ViaCord - BioInformant","headline":"3 Eerie Similarities between the Acquisition of Cord Blood Registry® (CBR) and ViaCord","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":327751000,"revenuePeriod":"2019-12-31","revenueHistory":[{"value":327751000,"period":"2019-12-31"},{"value":89707000,"period":"2019-12-31"},{"value":84131000,"period":"2019-09-30"},{"value":78109000,"period":"2019-06-30"},{"value":75804000,"period":"2019-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-466456000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":791227000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}